Alterity Therapeutics (ATH) Director Trades

Insider activity from ASX Appendix 3Y filings.

Trades shown
19
Bought (value)
$20,000
Sold (value)
$0
Net sentiment
+$20,000
DateDirectorTypeSharesPriceValueFiling
2026-09-02StamlerBuy———View
2026-09-02MarksBuy———View
2026-08-31Peter MarksExercise47,620$0.50$23,810View
2026-08-31David StamlerSell47,620——View
2026-06-17Unknown DirectorBuy———View
2026-06-15Julian BarbaczyExercise3,000,000——View
2026-01-07D StamlerBuy———View
2025-09-17Brian Meltzerother7,000,000——View
2025-09-17Unknown DirectorBuy———View
2025-04-29Unknown DirectorBuy———View
2025-04-24Peter MarksExercise606,061——View
2025-04-09Unknown DirectorBuy———View
2025-04-07Peter MarksBuy6,363,637$0.0031$20,000View
2025-01-06Unknown DirectorBuy———View
2024-12-30Brian MeltzerExercise60,000,000——View
2024-09-20BM / PMBuy———View
2024-08-31Brian MeltzerSell14,285,714——View
2024-01-11Unknown DirectorBuy———View
2024-01-08Peter MarksExercise33,333,332$0.0015$50,000View

Source: ASX Appendix 3Y filings (Corporations Act s205G). Director trades must be lodged with the ASX within 14 days of the change in interest. See the official methodology.